biosimilar use in the treatment of nsclc
Published 4 years ago • 61 plays • Length 7:07Download video MP4
Download video MP3
Similar videos
-
1:00
dr. kris on the impact of bevacizumab biosimilars in lung cancer
-
5:09
the use of biosimilars in her2 breast cancer
-
0:32
the potential of biosimilars in cancer treatment
-
1:48
dr. markman on the concept of biosimilars in oncology
-
1:09
dr. herbst on the bevacizumab biosimilar in lung cancer
-
0:41
similarity of biosimilars and biologics
-
38:15
biosimilars and biologics
-
9:26
the future direction of biosimilars
-
0:58
dr. hurvitz on the clinical use of biosimilars in oncology
-
7:22
an overview of biosimilarity
-
1:56
dr. schwartzberg on the use of therapeutic biosimilars in breast cancer
-
0:58
dr. denes on the use of biosimilars in oncology
-
10:01
fda approvals in sclc and a biosimilar, and japanese approvals in aml, ntrk tumors, and more
-
0:54
biosimilars: a promising new therapeutic option in cancer treatment
-
0:53
dr. puhalla on the value of biosimilars in oncology
-
0:57
dr. somer on the expansion of biosimilars in oncology
-
1:30
dr. mcbride on the potential impact of bevacizumab biosimilars in oncology
-
1:00
dr. ellis considers the use of biosimilars in oncology
-
0:54
dr. schmid on the role of biosimilars in oncology